Understanding the Arbitrary Legal Distinction Between Hemp and Marijuana
The arbitrary legal distinction hemp marijuana creates clinical confusion and inconsistent patient access to cannabis medicines. This regulatory framework complicates evidence-based prescribing and challenges clinicians. Understanding this distinction is…
Understanding Hemp and Marijuana as One Botanical Plant
Hemp and marijuana botanical identity is crucial for clinicians to understand the legal and biological distinctions in cannabis. This knowledge informs counseling on product quality and regulatory oversight. Recognizing their botanical identity helps…
FDA’s New Enforcement Guidance on Hemp CBD: Progress and Remaining Challenges
The FDA hemp CBD enforcement guidance marks a key step toward regulatory clarity in the hemp cannabinoid market. This guidance aims to improve safety standards for CBD products amid widespread variability. However, comprehensive congressional action is…
Nebraska Medical Cannabis Commission Approves Cultivators Amid Manufacturing Delays
The Nebraska medical cannabis cultivator regulations represent a key step in developing a functional supply chain. However, the manufacturing process remains incomplete, potentially delaying patient access. Clinicians should stay informed about these…
Colorado Targets Intoxicating Hemp Products with New Crackdown
Colorado hemp intoxicating products crackdown addresses safety and regulatory challenges posed by unregulated hemp-derived cannabinoids. Clinicians must understand enforcement actions to guide patients effectively. This crackdown impacts product…
Texas smokable hemp ban reversed: How THC flower returned to Austin shelves
Texas hemp smokable flower ban has been reversed, allowing THC flower back on Austin shelves. This change impacts legal access and patient treatment options. Regulatory clarity is essential for patient safety and clinical guidance.
India is ‘treasure trove’ of cannabis genetics, but policy will determine development
India cannabis genetics research reveals a vast untapped resource for therapeutic cannabis strains. Policy frameworks will determine how these genetics can be developed for clinical use. This research could expand pharmaceutical options for patients…
US: Proposed rule would create cannabis research facilities in Missouri
Missouri's new proposed rule for cannabis research facilities Missouri aims to fill critical gaps in clinical evidence on cannabis safety and efficacy. This development will enable better-informed prescribing decisions and improve patient outcomes. The…
Current state of hemp and cannabis
The FDA’s still deciding whether cannabis is medicine or Schedule I contraband, while patients quietly self-titrate in states where it’s apparently more legal than aspirin. Clinical evidence moves slower than the regulatory apparatus, which…
Hemp Farmers Face Regulatory Uncertainty Ahead of Planting Season
Hemp cultivation regulatory uncertainty is creating challenges for farmers preparing for the planting season. This uncertainty affects the supply chain and product availability for patients relying on hemp-derived therapies. Farmers and clinicians must…